Dyskinesia in Treatment-Naive and Stimulant-Treated Children With ADHD.

Related Articles

Dyskinesia in Treatment-Naive and Stimulant-Treated Children With ADHD.

J Atten Disord. 2016 Nov 18;:

Authors: Keresztény Á, Ferenczi-Dallos G, Velő S, Gádoros J, Balázs J

Abstract
OBJECTIVE: Stimulants are safe and effective medications for the treatment of ADHD. There are a number of case studies that report stimulant-induced dyskinesia. The aim of this study was to compare dyskinesia in a treated and a treatment-naive group of children with ADHD, and a healthy control group.
METHOD: Children aged 6 to 18 years were involved in the study (n = 158). Diagnosis of ADHD was measured with the Mini International Neuropsychiatric Interview Kid (MINI Kid). Dyskinesia was assessed with the Abnormal Involuntary Movement Scale (AIMS).
RESULTS: Before methylphenidate administration, the treated ADHD group showed significantly higher AIMS total score than the control group (p = .001) and the treatment-naive ADHD group (p < .001). We found the same pattern 1.5 hr after methylphenidate administration.
CONCLUSION: These results call attention that clinicians should take special care for the possible development of dyskinesia during the treatment of their ADHD patients with methylphenidate.

PMID: 27864427 [PubMed – as supplied by publisher]

via https://www.ncbi.nlm.nih.gov/pubmed/27864427?dopt=Abstract